Differential effect of obesity on cervical neoplastic progression and human papillomavirus persistence: A retrospective cohort study
The role of obesity in human papillomavirus (HPV) persistence and the development of cervical neoplasia remains incompletely understood. This study evaluates the independent effects of obesity, smoking, and age on high-risk HPV persistence and the development of high-grade cervical lesions (cervical intraepithelial neoplasia [CIN]2+), and assesses whether obesity improves prediction of CIN2+. This retrospective cohort study included 445 women who underwent high-risk HPV testing between December 2023 and December 2025. HPV persistence was defined as detection of the same HPV genotype in at least two consecutive tests performed ≥ 12 months apart. Body mass index was categorized as non-obese (<30 kg/m2) or obese (≥30 kg/m2). Multivariable logistic regression analyses were performed to identify independent determinants of HPV persistence and CIN2+. Receiver operating characteristic curve analysis was used to compare a baseline model including age and smoking with an extended model additionally including obesity. Persistent HPV infection was identified in 59 women (13.3%). Smoking was a strong independent predictor of HPV persistence (adjusted odds ratio [aOR]: 13.07; 95% confidence interval [CI]: 6.54–26.09; p < 0.001), and increasing age was also independently associated with persistence (aOR: 1.04 per year; 95% CI: 1.01–1.07; p = 0.023). Obesity was not independently associated with HPV persistence. CIN2+ was detected in 95 women (21.3%). Obesity was independently associated with CIN2+ (aOR: 1.96; 95% CI: 1.14–3.38; p = 0.015), whereas smoking and age were not significant predictors. The addition of obesity modestly improved discrimination for CIN2+ prediction (area under the curve [AUC] 0.545 vs. 0.587). Smoking and age are key determinants of HPV persistence, whereas obesity appears to be associated primarily with cervical neoplastic progression rather than viral persistence. The modest increase in AUC suggests limited but measurable predictive contribution of obesity to CIN2+ risk.
- Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–263. doi: 10.3322/caac.21834.
- Kou Y, Tang X, Liang D, et al. HPV genotypes in invasive cervical cancer: prevalence, risk attribution, and optimized vaccine strategies in western China. Front Public Health. 2024;12:1455931. doi: 10.3389/fpubh.2024.1455931
- McBride AA. Human papillomaviruses: diversity, infection and host interactions. Nat Rev Microbiol. 2022;20(2):95-108. doi: 10.1038/s41579-021-00617-5
- Wolf J, Kist LF, Pereira SB, et al. Human papillomavirus infection: epidemiology, biology, host interactions, cancer development, prevention, and therapeutics. Rev Med Virol. 2024;34(3):e2537. doi: 10.1002/rmv.2537
- Agrati C, Bartolini B, Bordoni V, et al. Emerging viral infections in immunocompromised patients: a great challenge to better define the role of immune response. Front Immunol. 2023;14:1147871. doi: 10.3389/fimmu.2023.1147871
- Majeed K, Ali H. Association of low-grade inflammation and oxidative stress with metabolic dysfunction in healthy obese individuals. AIMS Allergy Immunol. 2025;9(2):56-69. doi: 10.3934/allergy.2025004
- Tilg H, Ianiro G, Gasbarrini A, Adolph TE. Adipokines: masterminds of metabolic inflammation. Nat Rev Immunol. 2025;25(4):250-265. doi: 10.1038/s41577-024-01103-8
- Kim JW, Kim JH, Lee YJ. The role of adipokines in tumor progression and its association with obesity. Biomedicines. 2024;12(1):97. doi: 10.3390/biomedicines12010097
- Gilani A, Stoll L, Homan EA, Lo JC. Adipose signals regulating distal organ health and disease. Diabetes. 2024;73(2):169-177. doi: 10.2337/dbi23-0005
- Shaikh SR, Beck MA, Alwarawrah Y, MacIver NJ. Emerging mechanisms of obesity-associated immune dysfunction. Nat Rev Endocrinol. 2024;20(3):136-148. doi: 10.1038/s41574-023-00932-2
- Sultana A, Rana S. Mechanisms underlying obesity-malignancy connection: a systematic narrative review. J Physiol Biochem. 2025;81(2):403-439. doi: 10.1007/s13105-025-01084-9
- De Sanctis JB, Balda Noria G, García AH. Exploring how adipose tissue, obesity, and gender influence the immune response to vaccines: a comprehensive narrative review. Int J Mol Sci. 2025;26(2):862. doi: 10.3390/ijms26020862
- Kajabwangu R, Izudi J, Bazira J, Ssedyabane F, Turanzomwe S, Birungi A, et al. Effect of metabolic syndrome and its components on the risk and prognosis of cervical cancer: A literature review. Gynecol Oncol Rep. 2024;54:101438. doi: 10.1016/j.gore.2024.101438
- Zhao R, Sekar P, Bennis SL, Kulasingam S. A systematic review of the association between smoking exposure and HPV-related cervical cell abnormality among women living with HIV: implications for prevention strategies. Prev Med. 2023;170:107494. doi: 10.1016/j.ypmed.2023.107494
- World Health Organization. Obesity and overweight. Updated October 7, 2026. Accessed August 7, 2026. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
- Thakral A, Lee JJ, Hou T, et al. Smoking and alcohol by HPV status in head and neck cancer: a Mendelian randomization study. Nat Commun. 2024;15(1):7835. doi: 10.1038/s41467-024-51679-x
- Patra S, Shand H, Ghosal S, Ghorai S. HPV and male cancer: pathogenesis, prevention and impact. J Oman Med Assoc. 2025;2(1):4. doi: 10.3390/joma2010004
- Tsima BM, Motlhatlhedi K, Sharma K, et al. The association between smoking and cervical human papillomavirus infection among women from indigenous communities in western Botswana. PLoS ONE. 2024;19(6):e0302153. doi: 10.1371/journal.pone.0302153
- Urbute A, Thomsen LT, Belmonte F, Kesmodel US, Frederiksen K, Kjaer SK. The role of body mass index in incidence and persistence of cervical human papillomavirus infection. Ann Epidemiol. 2020;49:36-41. doi: 10.1016/j.annepidem.2020.07.011
- Liu SH, Chen HJ, Hsieh TH, et al. Excessive adiposity, metabolic health, and risks for genital human papillomavirus infection in adult women: a population-based cross-sectional study. BMC Obes. 2015;2(1):39. doi: 10.1186/s40608-015-0071-3
- Huang X, Zhao Q, Yang P, et al. Metabolic syndrome and risk of cervical human papillomavirus incident and persistent infection. Medicine. 2016;95(9):e2905. doi: 10.1097/MD.0000000000002905
- Ma K, Li S, Wu S, Zhu J, Yang Y. Impact of smoking exposure on human papillomavirus clearance among Chinese women: A follow-up propensity score matching study. Tob Induc Dis. 2023;21(March):1-11. doi: 10.18332/tid/161026
- Zhao M, Kang P, Zhu L, et al. Global pattern of persistent human papillomavirus infection in female genital tract: An update system review and meta-analysis. iScience. 2024;27(10):110991. doi: 10.1016/j.isci.2024.110991
